Health apps are not only empowering patients, but also providing clinicians with early access to important insights to support evidence-based care, says Dr Haidar Samiei, a consultant in emergency medicine and a clinical director…
Continue Reading
Patients whose blood cancer advances after initial treatments have one last therapeutic option: the engineering of their immune cells into a living medicine. But cancer is crafty and it often finds a way to…
Continue Reading
As we build technology to solve problems in healthcare- there is one really important asset that we can often overlook or maybe not give much time of day. But it is extremely essential because…
Continue Reading
COVID-19 forced a spike in policy-makers’ interest and willingness to invest in public health; a spike that is unfortunately retreating to the old business as usual. (President Biden, in his State of the Union…
Continue Reading
Spectrum.Life, a leading provider of mental health and wellbeing services for insurers, employers, employees, and students is pleased to announce the successful completion of a €5 million raise, resulting in a total of €9…
Continue Reading
A slew of biotech companies are pursuing research that could overcome limitations of current cell therapies. Startup creator Replay has a new subsidiary pushing toward the front of the pack with a therapeutic candidate on track to start its first human test this summer—about one year after Replay emerged from stealth. It owes this rapid progress to a cell therapy pioneer’s technology that has already been de-risked by a big pharmaceutical company.
Replay calls itself a genome writing company. With operations split between San Diego and London, the private equity-backed business launched last July with $55 million and a suite of technologies…
Subscribe for your weekly fix of health tech stories, wherever you get your news: Apple, Spotify or Twitter.Dr. Anne-Maree Cantwell, Partner at Empactful CapitalIn this episode, I sat down with Anne-Maree Cantwell, Venture Partner at…
Continue Reading
